.png)
.png)
.png)
Brand Name : F-PIME-S 1.5GM
Composition : Cefepime with Sulbactam Injection
Packing : 1.5GM
.jpg)
Composition : Cefepime with Sulbactam Injection
Packing : 1.5GM
F-PIME S 1.5 GM is a carefully developed combination of Cefepime and Sulbactam, designed to address a wide range of bacterial infections encountered in both outpatient practice and hospital settings. Cefepime, a fourth-generation cephalosporin, is well regarded for its potent bactericidal activity and its ability to remain stable against many commonly encountered beta-lactamase enzymes. The inclusion of Sulbactam further strengthens this formulation by inhibiting beta-lactamase enzymes produced by resistant bacteria, thereby protecting Cefepime and enhancing its overall effectiveness.In current clinical practice, where antibiotic resistance continues to be a growing concern, such combinations play an important role in ensuring effective treatment. F-PIME S 1.5 GM is often considered in moderate to severe infections where early intervention and reliable antibacterial coverage are essential to prevent disease progression and improve patient outcomes. Its consistent performance makes it a dependable option for clinicians managing complex infections.
Cefepime exerts its antibacterial effect by inhibiting the synthesis of the bacterial cell wall, an essential component for bacterial survival. By disrupting this process, it causes weakening of the cell wall, ultimately leading to bacterial cell death. It has a broad spectrum of activity and is effective against a variety of Gram-positive as well as Gram-negative organisms.However, the effectiveness of many beta-lactam antibiotics can be reduced due to the production of beta-lactamase enzymes by resistant bacteria. Sulbactam acts as a beta-lactamase inhibitor, binding to these enzymes and rendering them inactive. This protective action allows Cefepime to remain active against organisms that would otherwise be resistant.Together, this combination offers enhanced antibacterial coverage and a more sustained therapeutic effect, making it particularly useful in treating complicated, mixed, and hospital-acquired infections.
F-PIME S 1.5 GM is indicated for the treatment of a variety of bacterial infections, including:
It is also considered a suitable option in situations where mixed infections are suspected or where resistance to standard antibiotics may be a concern.
F-PIME S 1.5 GM should always be administered under the supervision of a qualified healthcare professional. It can be given either as an intravenous infusion or as an intramuscular injection, depending on the severity and nature of the infection.The dosage regimen is individualized based on several factors, including the type and location of infection, the patient’s overall health status, renal function, and response to therapy. In more severe or life-threatening infections, higher or more frequent dosing may be required, as determined by the treating physician.It is important to complete the full prescribed course of treatment, even if symptoms improve earlier, to ensure complete eradication of the infection and to reduce the risk of developing resistance.
F-PIME S 1.5 GM brings together the strength of Cefepime and the protective action of Sulbactam to offer a well-balanced and dependable solution for managing serious bacterial infections. This combination is particularly useful in today’s clinical scenario, where resistance patterns often limit the effectiveness of single-agent therapies.Its broad antibacterial coverage and consistent clinical performance make it suitable for both empirical therapy, where immediate treatment is required, and targeted therapy based on culture sensitivity results. Manufactured under stringent quality standards, it ensures reliability, safety, and uniformity across batches.For healthcare professionals, F-PIME S 1.5 GM represents a practical and confident choice when dealing with infections that demand prompt, effective, and sustained antibacterial action.